A new study suggests that adults with allergy symptoms have a higher risk of developing irritable bowel syndrome.
Help for people with IBS
A new study suggests that adults with allergy symptoms have a higher risk of developing irritable bowel syndrome.
In the last two posts I wrote about some of the recognized onset events for irritable bowel syndrome (IBS). Those included genetics, gender, infection and inflammation, and environment. The remaining two factors include bacterial overgrowth, and abuse.
In my last post I wrote about a couple of the recognized onset events for irritable bowel syndrome (IBS). Those included genetics and gender. Additional factors include infection and inflammation, and environmental factors.
Researchers have determined, however, is that there appears to be a set of common factors among IBS patients that may give clues to potential treatments.
If you suffer from irritable bowel syndrome (IBS) you may have experienced impacts to your lifestyle because of the condition. Many IBS patients are reluctant to venture into unknown situations for fear that they will be unable to find a bathroom in time.
For diarrhea predominant IBS, or IBS-D, the treatment traditionally used includes peppermint and antispasmodics. Since I suffer from IBS-D, I decided to try this out. I went to a local health food store and picked up some peppermint capsules and have been taking 1 capsule, twice a day.
There can be several other conditions that are co-existent with irritable bowel syndrome (IBS). One of those conditions that has recently been identified is fibromyalgia.
There have been several new drugs that were trumpeted as great treatments for irritable bowel syndrome (IBS) in recent years. Unfortunately they have not demonstrated the results that were anticipated. But as it turns out, there are older treatments that apparently work the best for IBS.
If you are female and have been diagnosed with irritable bowel syndrome (IBS) there is a higher likelihood that you will also be diagnosed with endometriosis than if you did not have IBS.
Zelnorm was marketed in Canada between March, 2002 and March, 2007 for the treatment of IBS symptoms. At the request of the Canadian health department, Novartis pulled the drug from the market. This was based on analysis of clinical data the showed a significant increase in the incidence or cardiovascular events in people taking Zelnorm.